Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 252

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1A
Chunk 252
---
 a result of many factors currently unknown to us, and we may need to seek additional funds sooner than planned, through
public or private equity or debt financings or other third-party funding or a combination of these approaches. Even if we believe we
have sufficient funds for our current or future operating plans, we may seek additional capital if market conditions are favorable or
based upon specific strategic considerations.

Any
additional fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to
develop and commercialize our products and services. In addition, we cannot guarantee that future financing will be available in sufficient
amounts or on terms acceptable to us, if at all. Moreover, the terms of any financing may adversely affect the holdings or the rights
of our stockholders and the issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may
cause the market price of our shares to decline. The sale of additional equity or convertible securities may dilute our stockholders.
In addition, the future issuance of shares of Class B common stock may be dilutive to the holders of Class A common stock, particularly
with respect to their voting power. The incurrence of indebtedness would result in increased fixed payment obligations, and we may be
required to agree to certain restrictive covenants, such as limitations on our ability to make certain dividends, incur additional debt,
limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely
impact our ability to conduct our business.

If
we are unable to obtain funding on a timely basis, we may be required to significantly curtail, delay or discontinue our operations or
be unable to expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially affect our
business, financial condition and results of operations.

-8-

Our
independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern, which
may hinder our ability to obtain future financing.

Our
independent registered public accounting firm included in its opinion for the years ended December 31, 2024 and 2023 an explanatory paragraph
referring to our recurring losses from operations and expressing substantial doubt in our ability to continue as a going concern without
additional capital becoming available. Our ability to continue as a going concern is dependent upon our ability to obtain additional
equity or debt financing, reduce expenditures and generate significant revenue. Our financial statements as of December 31